Live from the NIH registry
Studies recruiting near Lansing right now
Top 25 of 170 recruiting studies, sorted by proximity — each links to its official registry page
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma
Phase 3
Interventional 5,951 participants sought
Michigan State University — East Lansing, Michigan (4.2 mi)
· Sponsor: Children's Oncology Group
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
Narcolepsy Type 1, Narcolepsy Type 2
Phase 2, Phase 3
Interventional 786 participants sought
Alkermes Investigational Site — Lansing, Michigan (1.3 mi)
· Sponsor: Alkermes, Inc.
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Sparrow Hospital — Lansing, Michigan (1.3 mi)
· Sponsor: SWOG Cancer Research Network
C-Brace Prospective Registry
Pareses, Lower Extremity
N/A
Observational 250 participants sought
Wright & Filippis x Ottobock.care — Lansing, Michigan (1.3 mi)
· Sponsor: Otto Bock Healthcare Products GmbH
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8
Phase 2
Interventional 474 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Breast Neoplasms, Breast Cancer
Phase 2
Interventional 5,000 participants sought
Herbert-Herman Cancer Center, Sparrow Hospital — Lansing, Michigan (1.3 mi)
· Sponsor: QuantumLeap Healthcare Collaborative
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
Multiple conditions
Phase 2
Interventional 98 participants sought
Karmanos Cancer Institute at McLaren Greater Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: NRG Oncology
Engaging College Students in Developing and Testing a Video-based Intervention for HPV Vaccination Promotion
N/A - Healthy Subjects
N/A
Interventional 123 participants sought
Michigan State University — East Lansing, Michigan (4.2 mi)
· Sponsor: Michigan State University
Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies
Advanced Solid Tumor
Phase 1
Interventional 60 participants sought
Karmanos Cancer Institute at McLaren Greater Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: Barbara Ann Karmanos Cancer Institute
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
Uncontrolled Gout
Phase 3
Interventional 270 participants sought
June DO PC — Lansing, Michigan (1.3 mi)
· Sponsor: Amgen
Patient Retrospective Outcomes (PRO)
Chronic Pain
N/A
Observational 15,000 participants sought
Michigan Orthopedic Center — Lansing, Michigan (1.3 mi)
· Sponsor: Boston Scientific Corporation
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
AL Amyloidosis
Phase 3
Interventional 338 participants sought
Karmanos Cancer Institute at McLaren Greater Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Heart Failure
Phase 3
Interventional 6,712 participants sought
Sparrow Clinical Research Institute — Lansing, Michigan (1.3 mi)
· Sponsor: Boehringer Ingelheim
SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Hemophilia A With Inhibitor, Hemophilia B With Inhibitor
Phase 4
Interventional 55 participants sought
MSU Center for Bleeding and Clotting Disorders — Lansing, Michigan (1.3 mi)
· Sponsor: American Thrombosis and Hemostasis Network
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: SWOG Cancer Research Network
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
McLaren Greater Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: Novo Nordisk A/S
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Lansing, Michigan (1.3 mi)
· Sponsor: Medtronic
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
Malignant Solid Neoplasm
N/A
Observational 2,062 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: SWOG Cancer Research Network
Treating Chronic Cervicogenic Head and Neck Pain
Cervicogenic Headache, Neck Pain, Posterior
Phase 1, Phase 2
Interventional 30 participants sought
Michigan State University — East Lansing, Michigan (4.2 mi)
· Sponsor: Michigan State University
Support for Bereaved Cancer Caregivers
Bereavement, Cancer
N/A
Interventional 70 participants sought
Michigan State University College of Nursing — East Lansing, Michigan (4.2 mi)
· Sponsor: Michigan State University
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular
Phase 3
Interventional 750 participants sought
Michigan State University — East Lansing, Michigan (4.2 mi)
· Sponsor: Children's Oncology Group
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
Hypertension, Hypertension, Systolic
N/A
Interventional 316 participants sought
UMH-Sparrow Clinical Research — Lansing, Michigan (1.3 mi)
· Sponsor: Orchestra BioMed, Inc
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8
Phase 3
Interventional 356 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: NRG Oncology
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
Locally Advanced Cervical Adenocarcinoma, Locally Advanced Cervical Adenosquamous Carcinoma
Phase 3
Interventional 336 participants sought
University of Michigan Health - Sparrow Lansing — Lansing, Michigan (1.3 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
Narcolepsy Type 2
Phase 3
Interventional 176 participants sought
Alkermes Investigational Site — Lansing, Michigan (1.3 mi)
· Sponsor: Alkermes, Inc.